China is the larger producer, with a deeper base of intermediates and very large plants for many actives. India is a strong generic producer with good synthesis skills, wide export registration experience and growing technical capacity.
Quality depends on the plant, not the country. Both have excellent and weak suppliers. The real differences lie in supply chain depth, regulatory track record and risk.
Where China is stronger
- China has a deeper chain of intermediates and raw materials, so many plants make more of their own inputs.
- Very large plants for high-volume actives give strong scale for those molecules.
- Chinese plants supply many intermediates and some technicals to Indian formulators and synthesis plants.
Where India is stronger
- Many Indian plants already supply registered products to regulated markets, so they know what dossiers and batch data must show.
- India has a national GLP programme within the OECD data acceptance system, so local labs can produce study data many regulators accept.
- Indian plants are often willing to work on complex multi-step molecules and contract manufacture.
- English is the working language of business and documents, which eases dossiers and audits.
- India gives you a second source, which reduces your exposure to supply shocks in one country.
Dependence and supply risk
Many Indian plants depend on Chinese intermediates for at least some products. When Chinese supply tightens, through plant closures, environmental checks or trade measures, Indian output and lead times can feel it too. So an Indian source is not fully independent of China unless its key inputs are made in India or elsewhere.
Ask any Indian supplier where each key starting material comes from and how much stock it keeps. A plant that makes its own key intermediate is a stronger second source. The broader shift is covered in China-plus-one sourcing for Indian chemicals.
Both countries also face environmental enforcement. Pollution control actions can halt plants in clusters in either country, so check consents and effluent treatment at any site you use.
How to compare two sources
Compare sources on the same basis, not on headline quotes. For your product and market, ask each one the same questions.
- Does the source have the registration status and data your regulator needs?
- Does its five-batch analysis show a purity and impurity profile that meets your specification?
- Does it make its own key intermediates, or buy them in?
- What lead time can it commit to in writing, and what has it achieved over the past year?
- What do independent tests on its lots show, compared with its COAs?
Choose before you file
Registration often ties you to a named source, so compare carefully before you file. A switch later can mean new data and a new approval.
Next step
We assess Indian sources on registration data, impurity profile, input dependence and testing, so you can compare them fairly with your current supply. Book a free sourcing review.